Skip to main content
. 2021 Jul 6;11(16):8027–8042. doi: 10.7150/thno.61207

Table 1.

List of included articles on RFs derived of MRI. In the second column # are the number of patients enrolled retrospectively (R) or prospectively (P). In the fourth column the volume of interest (VOI) is presented accompanied by the type of segmentation in brackets M = manual, SA = semiautomatic and A = fully automatic. The last column contains information on validation. “e” stands for external validation and “I” for internal. The number stands for the number of cohorts used. 2 means one for development and one for testing.

Prostate cancer detection
Study # Imaging Modality VOI (Segmentation) Endpoint(s) Results Validation
Cameron et al. 67 5 (R) T2w, ADC PCa (A +M) PCa detection RF model outperformed conventional mpMRI feature models. i (LOO)
Cameron et al. 66 13 (R) T2w, DWI, DCE PCa (A) Classifiers for PCa detection RF model outperformed conventional mpMRI feature models. i (CV, LOO)
Viswanath et al. 68 85 (R) T2w PCa, PZ, central gland (M) Classifier for voxel-wise PCa detection Boosted Decision Tree classifier has the highest ROC-AUC for detecting PCa., Boosted Quadratic-Discriminant Analysis is the most accurate and robust in detection of PCa extent across three sites. The ground truth was established by whole mount histology. e (CV with external centers)
Khalvati et al. 69 20 (R ) T2w, DWI, CDI, CHB-DWI PCa, prostate (M) Classifier for PCa detection Support vector machine classifier improved PCa auto-detection. i (LOO)
Xu et al. 70 331 (R) T2w, DWI, ADC PCa Benign vs. malignant lesions BpMRI improved discrimination between benign and malignant lesions. i (2)
Bonekamp et al. 71 316 (R) T2w, DWI and ADC PCa, PZ, prostate (M) PCa ISUP ≥2 Quantitative ADC measurement improves differentiation of benign vs malignant lesions, ML comparable, performance of zone-specific models was lower. i (2+CV)
Sidhu et al. 72 76 (R) T1w, T2w, DWI, ADC PCa in TZ (M) PCa detection in TZ TZ derived RF can discriminate TZ-PCa. i (LOO)
Ginsburg et al. 73 80 (R) T2w, DWI, DCE PCa, TZ, prostate (M) PCa detection in TZ and PZ TZ-specific classifier significantly improves accuracy of PZ-PCa detection. e (3 institutions)
Parra et al.114 52 (R) DCE Habitat = biopsy +15 mm (M) PCa detection (significant) Habitats from DCE predict clinically significant PCa well. i (LOO)
Khalvati et al. 74 30 (R) T2w, ADC, CHB-DW, CDI PCa (A) Framework for PCa detection Proposed framework (MPCaD can be utilized to detect and localize PCa. i (LOO)
Wang et al. 75 54 (R) T2w, CHB-DW PCa, histological-radiological correlation (M) Classifier for PCa detection (significant) SVM classifier improves performance of PI-RADS v2 for clinically relevant PCa. i (LOO)
Gholizadeh et al.76 16 (P) T2WI, DWI, DTI PCa in PZ(M) Differentiation pf PCa and non-PCa Voxel‐based supervised machine learning models generated a binary classification of cancer probability maps. i (2+LOO)
Hu et al.
77
136 (P) DWI, ADC PCa (M) PCa detection A mixed model based on the clinically independent risk factors and mp-MRI radiomics score showed the best performance. i (2)
Woźnicki et al.78 191 (R) T2w, ADC PCa + Prostate (M) PCa detection and clinical significance An ensemble machine learning model combining radiomics, PI-RADS, prostate specific antigen density and digital rectal examination
resulted in a good predictive performance.
i (2+CV)
Qi et al.
79
199 (R) T2w, ADC, DCE PCa (M) PCa prediction on patients with PSA level of 4-10ng/ml The combined model incorporating all sequences, age, PSA density and the PI‐RADS v2 score yielded good performance for prediction of PCa. i (2)
Dulhanty et al. 115 101 (R) ADC, CHB-DWI Prostate zones (M) PCa detection based on 10 anatomical zones Zone-level radiomic sequences distinguish between positive and negative zones. i (CV)
Bleker et al.
80
206 (P) T2w, DWI, ADC, DCE PCa (SA) csPCa in PZ Addition of DCE-RFs does not improve performance of T2w- and DWI-RF based models. Multivariate RF selection with extreme gradient boosting outperformed univariate selection. i (2)
Wu et al.81 90 (R) T2w, ADC PCa in TZ (M) Differentiation of PCa inTZ Proposed models using quantitative ADC, shape and texture features, show good performance for TZ PCa detection and remained accurate when comparing TZ PCa with stromal BPH and in smaller lesions. i (CV)
Kwon et al. 82 344 (R T2w, DCE, DWI, proton density-weighted Prostate, PZ, PCa (M) Detection of csPCA
Classification methods
Random forest classification showed the highest AUC. i (2)
Gleason score
Hectors et al.83 64 (R) T2w, ADC, diffusion kurtosis imaging maps PCa (unknown) Aggressiveness (GS, Gene expression, Decipher) 14 RF with significant correlation to GS, 40 DWI features with significant correlation to Gene expression, ML models with excellent performance to predict Decipher score ≥ 6. i (CV)
Chaddad et al. 85 99 (R) T2w, ADC PCa (M) GS grouping (6/3+4/4+3) Joint Intensity Matrix-derived RF (n=5) are independent predictors of GS. i (2)
Chaddad et al. 84 99 (R) T2w, ADC PCa (A) GS grouping (6/3+4/4+3) T2w and ADC derived RF can predict GS. i (CV)
Sun et al. 119 30 (R) T2w PCa on histology (M) GS, Risk groups ADC, GLCM and GLRLM discriminate between high grade and low grade PCa. The combination further improved AUC. i (CV)
Jensen et al. 86 112 (R) T2w, DWI PCa (M) GS, risk group Zonal-specific DWI and T2w derived RF differentiate between PCa lesions of all GS. i (LOO + CV)
Chen et al. 87 381 (R) ADC, T2w PCa, prostate(M) PCa/non-PCa, high grade GS /low grade GS 6 compared to PI-RADSv2 T2w and ADC RF show high efficacy in distinguishing PCa vs non-PCa and high-grade vs low-grade PCa. i (2)
Toivonen et al. 88 62 (R) T2w, DWI, T2-mapping PCa GS T2w and DWI derived RF show good classification performance for GS of PCa. i (LPOCV + CV)
Zhang et al. 89 166 (R) T2w, ADC, DCE PCa (M) PCa upgrading T2w, ADC and DCE derived RF can predict GS upgrading from biopsy to radical prostatectomy. i (2)
Min et al. 90 280 (R) T2w, DWI, ADC PCa (M) PCa detection (significant) MpMRI derived RF discriminate between GS 3+4 or lower. I (CV)
Li et al. 91 63 (R) T2w, ADC, DCE PCa (M) GS in CG PCa Support vector machine classification achieves accurate GS classification of PCa in central gland. i (CV)
Rozenberg et al. 92 54 (R) ADC PCa (M) Prediction of GS upgrading and Differentiation of GS 3+4 and 4+3 ADC derived texture features are not predictive of GS upgrading after radical prostatectomy. i (CV)
McGarry et al. 120 48 (P) T2w, ADC, DCE PCa on histology (M) Gleason probability maps RF based mapping successfully stratifies high- and low-risk PCa. i (2)
Penzias et al. 121 36 (R) T2w PCa on histology (M) GS, risk group, correlation with QH RF and quantitative histomorphometry features correlated with these RF are predictive for of GS. i (2)
Fehr et al. 93 217 (R) T2w, ADC PCa (M) GS risk group differentiation Automatic classifiers achieve accurate classification of GS. i (CV)
Hou et al. 94 263 (R) T2w, DWI, ADC PCa, (M) Clincially significant PCa (GS≥7) in PIRADS 3 lesions Radiomics ML model of all sequences has potential to predict csPCa in PIRADS 3 lesions to guide biopsy. i (CV)
Li et al. 95 381 (R) T2w, ADC PCa in TZ and PZ (M) Clincically significant PCa Radiomics model can predict csPCa with high accuracy (AUC ≥-98). i (2)
Gong et al.116 489 (R) T2w, DWI, ADC Prostate Identification of high grade PCa (>GS7) DWI RF-model and combination of T2w and DWI achieved high accuracy in prediction of GS >7. i (2, CV)
Algohary et al. 96 231 (R) T2w, ADC PCa lesion, peritumoral area (M) Differentiation of PCa Risk Groups according to D'Amico Combination of peritumoral and intratumoral RFs improved the risk stratification results by 3-6% compared to intra-tumoral features alone. e (2)
Gugliandolo et al. 97 65 (R) T2w Prostate excluding urethra and dominant intraprostatic lesions (M) Prediction of GS, PIRADS v2 Score and Risk Group Radiomic signature consisting of the combination of 3D GLCM and intensity domain category features were able to discriminate between low- and intermediate-grade malignancy. i (CV, LOO)
Zhang et al. 98 159 (R) T2w, DWI, ADC PCa (M) Discrimintation of csPCa and clincially insignificant PCa A radiomic signature of 10 features, was significantly associated with csPCa. A nomogram of this signature and ADC values showed even better AUCs. e (2, CV)
Algohary et al. 99 56 (R) T2w, ADC PCa (M) Prediction of csPCa in active surveillance patients 7 T2w-based and 3 ADC-based RF exhibited statistically significant differences between malignant and normal regions in the training groups. The 3 constructed ML models yielded good accuracy i (CV)
Abraham et al. 100 162 (R) T2w, ADC, high B-Value Diffusion-Weighted (BVAL) PCa (A) Classification of Grade Groups The novel method using texture features and stacked sparse autoencoder was able to classify PCa grade groups moderately. i (2, CV)
Extracapsular extension
Ma et al. 120 119 (R) T2w PCa (M) ECE of PCa T2w derived RF predict side specific ECE. i (2)
Ma et al. 90 210 (R) T2w PCa (M) ECE prior to RP T2w derived RF outperformed radiologist in predicting ECE. i (2)
Stanzione et al. 103 39(R) T2w, AdC PCa index Lesions (M) Classifier for ECE prediction Bayesian Network was the best classifier for ECE prediction. i (CV)
Losnegard et al. 104 228 (R) T2w, ADC, DCE Prostate, PCa (M+A) ECE Prediction in high and unfav. Intermediate risk PCa 12 RF extracted from manual segmentation combined with a Random Forest classifier can predict ECE with an AUC of 0.74.
Features from T2W and ADC showed a good performance. A combined model performed even better.
i (CV)
Xu et al. 105 95 (R) T2w, DWI, ADC, DCE PCa (M) ECE 8 RF were used to build a radiomics model with an AUC of 0.92. A radiomics nomogram with clinical features yielded similar results. i (2)
Bone metastasis
Wang et al. 106 176 (R) T2w, DCE T1w PCa (M) Bone metastasis prediction T2w and DCE derived RF were predictors for BM. i (2)
Zhang et al. 107 116 (R) T2, DWI, DCE PCa (M) Prediction of bone metastasis in newly diagnosed PCa The radiomics nomogram based on 11 RFs and clinical risk factors, showed good performance to promote individualized prediction of bone metastasis. i (2)
Biochemical recurrence
Bourbonne et al. 109 107 (R) T2w, ADC PCa (SA) Prediction of BCR and biochemical relapse free survival after RP in high risk PCa One ADC derived RF (SZEGLSZM) was predictive for BCR and bRFS (AUC 0.76). i (2)
Bourbonne et al. 108 195 (R) ADC PCa (SA) BCR External validation of the identified ADC derived RF (SZEGLSZM) for BCR and bRFS prediction after RP. e (2)
Shiradka et al. 110 120 (R) T2w and ADc PCa, prostate (M) BCR after RP or RT BpMRI RF-trained machine learning classifier can be predictive of BCR. e (2)
Zhong et al.117 91 (R) T1w, T2w, DWI Prostate (M) BRC of localized PCa after RT and neoadjuvant endocrine therapy. MRI derived RFs can predict BCR after RT with good performance. i (2, CV)
Treatment response
Abdollahi et al. 111 33 (P) T2w, ADC, pre- and post IMRT PCa (M) Therapy response (RT), GS, T-stage T2w and ADC derived RF and ML correlate with IMRT response. i (CV)
Toxicity
Abdollahi et al. 122 33 (P) T2w, ADC Rectal wall (M) Rectal toxicity Pre-IMRT MRI RF predict rectal toxicity. i (CV)
Segmentation
Sunoqrot et al. 118 635 (R) T2w Prostate gland (M) Quality System for automated prostate segmentation Proposal of a quality check for automated segmentation of the prostate in T2W MR image. e (2, CV)
Lay et al.
112
224 (R) T2w, ADC, DWI PCa (M) Prostate and TZ (A) PCa segmentation Random forest sampling strategy and instance-level weighting improve PCa detection performance compared to support vector machine. i (2, CV)
Giannini et al.
113
58 (R) T2w, ADC PCa (M) PCa segmentation Proposed method with GLCM texture features computed on ADC and T2w images reduced the number of false positives and increased the precision of PCa detection. i (CV)

Abbreviations: ADC=Apparent diffusion coefficient, BCR=biochemical recurrence, bpMRI=biparametric magnetic resonance imaging, bRFS=biochemical recurrence free survival, CDI=current density imaging, csPCa= clinically significant prostate cancer, CV=cross validation, DCE=dynamic contrast enhanced, DTI= diffusion. tensor imaging, DWI=diffusion weighted imaging, GLCM= gray level co-occurrence matrix, GLRLM=grey-level run length matrix, GS=Gleason score, IMRT=intensity modulated radiotherapy, LOO=leave one out, LPOCV=leave-pair-out cross-validation, M=manual confirmation, ML=machine learning, mpMRI=multiparametric magnetic resonance imaging, PCa=Prostate cancer; PZ=peripheral zone, RF=radiomic feature, ROC-AUC=are under the receiver operating characteristics curve, RP=radical prostatectomy, T1w= T1-weighted imaging, T2w=T2-weighted imaging, TZ= transitional zone.